FocusCANCER PHARMACOLOGY

Eco-evolution of cancer resistance

See allHide authors and affiliations

Science Translational Medicine  24 Feb 2016:
Vol. 8, Issue 327, pp. 327fs5
DOI: 10.1126/scitranslmed.aaf3802

Article Information

vol. 8 no. 327 327fs5

DOI: 
https://doi.org/10.1126/scitranslmed.aaf3802
PubMed: 
26912901
Published By: 
American Association for the Advancement of Science
Print ISSN: 
1946-6234
Online ISSN: 
1946-6242
History: 
  • .
Copyright & Usage: 
Copyright © 2016, American Association for the Advancement of Science

Author Information

  1. Giannoula L. Klement1,2,3,*
  1. 1Tufts University School of Medicine, Boston, MA 20111, USA.
  2. 2Sackler School of Graduate Biomedical Sciences, Tufts University, Boston, MA 02111, USA.
  3. 3Floating Hospital for Children at Tufts Medical Center, Boston, MA 02111, USA.
  1. ↵*E-mail: glakkaklement{at}tuftsmedicalcenter.org

Altmetric

Article usage

Article usage: February 2016 to February 2021

AbstractFullPdf
Feb 20164545370566
Mar 20162105169276
Apr 20162733272
May 20162912636
Jun 20162361030
Jul 20161381122
Aug 2016363815
Sep 2016201621
Oct 2016182820
Nov 201612679
Dec 2016121916
Jan 2017126515
Feb 201790713
Mar 20178539
Apr 2017124715
May 20171331316
Jun 20175614
Jul 20178668
Aug 20177645
Sep 20179356
Oct 201710759
Nov 201710463
Dec 20179528
Jan 20185934
Feb 20187983
Mar 20185246
Apr 20186467
May 20185857
Jun 20186000
Jul 20185498
Aug 20184132
Sep 20183833
Oct 20184677
Nov 201847134
Dec 201852127
Jan 20193235
Feb 20194986
Mar 201943114
Apr 201979157
May 201933126
Jun 201948108
Jul 20192954
Aug 20193987
Sep 20194232
Oct 20193493
Nov 20194284
Dec 20193667
Jan 202048182
Feb 20203252
Mar 20203773
Apr 20204593
May 2020561213
Jun 20202360
Jul 202028811
Aug 20202272
Sep 20204652
Oct 202056113
Nov 2020381010
Dec 2020602014
Jan 20213150
Feb 202168113

View Full Text

Article Tools

  • Email
  • Download Powerpoint
  • Print

  • Alerts
  • Citation tools

  • Eco-evolution of cancer resistance

    By Giannoula L. Klement

    Science Translational Medicine : 327fs5

    Contrary to high-dose cytotoxic chemotherapy, where they proliferate unopposed, drug-resistant cancer cells may be at an evolutionary disadvantage in presence of low-dose chemotherapy owing to the high metabolic cost of their resistance mechanisms (Enriquez-Navas et al., this issue).

    CiteULike logo Connotea logo del.icio.us logo Digg logo Facebook logo Google logo Mendeley logo Reddit logo Twitter logo

My saved folders

Stay Connected to Science Translational Medicine

Related Content

Similar Articles in:

Citing Articles in: